Canada Life’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Canada Life’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-87,893	Closed	-$4.74M	–	2736
2017 Q4	$4.74M	Sell	87,893 -57	-0.1%	-$3.12K	0.01%	726
2017 Q3	$4.99M	Sell	87,950 -1,409	-2%	-$82.5K	0.01%	696
2017 Q2	$5.37M	Sell	89,359 -201,664	-69%	-$11.5M	0.01%	670
2017 Q1	$15.8M	Buy	+291,023	New	+$14.3M	0.04%	385

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Canada Life's BIVV Position: Q1 2018 in Review

Canada Life sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 87,893 shares — an estimated $4.74M sold.

Canada Life first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $15.8M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Canada Life reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Canada Life sold 87,893 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4.74M.
Canada Life first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Canada Life's Bioverativ Inc. Common Stock position peaked at $15.8M in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Canada Life's 13F filing for Q1 2018, filed 10 May 2018.